Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2018

Open Access 01-12-2018 | Study protocol

Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol

Authors: Helge Hebestreit, Larry C. Lands, Nancy Alarie, Jonathan Schaeff, Chantal Karila, David M. Orenstein, Don S. Urquhart, Erik H. J. Hulzebos, Lothar Stein, Christian Schindler, Susi Kriemler, Thomas Radtke, the ACTIVATE-CF Study Working Group

Published in: BMC Pulmonary Medicine | Issue 1/2018

Login to get access

Abstract

Background

Physical activity (PA) and exercise have become an accepted and valued component of cystic fibrosis (CF) care. Regular PA and exercise can positively impact pulmonary function, improve physical fitness, and enhance health-related quality of life (HRQoL). However, motivating people to be more active is challenging. Supervised exercise programs are expensive and labour intensive, and adherence falls off significantly once supervision ends. Unsupervised or partially supervised programs are less costly and more flexible, but compliance can be more problematic. The primary objective of this study is to evaluate the effects of a partially supervised exercise intervention along with regular motivation on forced expiratory volume in 1 s (FEV1) at 6 months in a large international group of CF patients. Secondary endpoints include patient reported HRQoL, as well as levels of anxiety and depression, and control of blood sugar.

Methods/design

It is planned that a total of 292 patients with CF 12 years and older with a FEV1 ≥ 35% predicted shall be randomised. Following baseline assessments (2 visits) patients are randomised into an intervention and a control group. Thereafter, they will be seen every 3 months for assessments in their centre for one year (4 follow-up visits). Along with individual counselling to increase vigorous PA by at least 3 h per week on each clinic visit, the intervention group documents daily PA and inactivity time and receives a step counter to record their progress within a web-based diary. They also receive monthly phone calls from the study staff during the first 6 months of the study. After 6 months, they continue with the step counter and web-based programme for a further 6 months. The control group receives standard care and keeps their PA level constant during the study period. Thereafter, they receive the intervention as well.

Discussion

This is the first large, international multi-centre study to investigate the effects of a PA intervention in CF with motivational feedback on several health outcomes using modern technology. Should this relatively simple programme prove successful, it will be made available on a wider scale internationally.

Trial registration

ClinicalTrials.gov Identifier: NCT01744561; Registration date: December 6, 2012.
Literature
1.
go back to reference Dwyer TJ, Elkins MR, Bye PT. The role of exercise in maintaining health in cystic fibrosis. Curr Opin Pulm Med. 2011;17:455–60.PubMed Dwyer TJ, Elkins MR, Bye PT. The role of exercise in maintaining health in cystic fibrosis. Curr Opin Pulm Med. 2011;17:455–60.PubMed
2.
go back to reference Rand S, Prasad SA. Exercise as part of a cystic fibrosis therapeutic routine. Expert Rev Respir Med. 2012;6:341–51. quiz 352CrossRefPubMed Rand S, Prasad SA. Exercise as part of a cystic fibrosis therapeutic routine. Expert Rev Respir Med. 2012;6:341–51. quiz 352CrossRefPubMed
3.
go back to reference Radtke, T, Nevitt SJ, Hebestreit H, Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database Syst Rev. 2017;11:CD002768. Radtke, T, Nevitt SJ, Hebestreit H, Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database Syst Rev. 2017;11:CD002768.
4.
go back to reference Selvadurai HC, Blimkie CJ, Meyers N, Mellis CM, Cooper PJ, Van Asperen PP. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol. 2002;33:194–200.CrossRefPubMed Selvadurai HC, Blimkie CJ, Meyers N, Mellis CM, Cooper PJ, Van Asperen PP. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol. 2002;33:194–200.CrossRefPubMed
5.
go back to reference Kriemler S, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Stussi C, Hebestreit H. Effect of supervised training on FEV1 in cystic fibrosis: a randomised controlled trial. J Cyst Fibros. 2013;12:714–20.CrossRefPubMed Kriemler S, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Stussi C, Hebestreit H. Effect of supervised training on FEV1 in cystic fibrosis: a randomised controlled trial. J Cyst Fibros. 2013;12:714–20.CrossRefPubMed
6.
go back to reference Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, Strandvik B, McKenzie SG. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European epidemiologic registry of cystic fibrosis. Eur Respir J. 2001;18:298–305.CrossRefPubMed Navarro J, Rainisio M, Harms HK, Hodson ME, Koch C, Mastella G, Strandvik B, McKenzie SG. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European epidemiologic registry of cystic fibrosis. Eur Respir J. 2001;18:298–305.CrossRefPubMed
7.
go back to reference Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Schenk T, Posselt HG, Kriemler S. Long-term effects of a partially supervised conditioning programme in cystic fibrosis. Eur Respir J. 2010;35:578–83.CrossRefPubMed Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Schenk T, Posselt HG, Kriemler S. Long-term effects of a partially supervised conditioning programme in cystic fibrosis. Eur Respir J. 2010;35:578–83.CrossRefPubMed
8.
go back to reference Gulmans VA, de Meer K, Brackel HJ, Faber JA, Berger R, Helders PJ. Outpatient exercise training in children with cystic fibrosis: physiological effects, perceived competence, and acceptability. Pediatr Pulmonol. 1999;28:39–46.CrossRefPubMed Gulmans VA, de Meer K, Brackel HJ, Faber JA, Berger R, Helders PJ. Outpatient exercise training in children with cystic fibrosis: physiological effects, perceived competence, and acceptability. Pediatr Pulmonol. 1999;28:39–46.CrossRefPubMed
9.
go back to reference Tudor-Locke C, Lutes L. Why do pedometers work?: a reflection upon the factors related to successfully increasing physical activity. Sports Med. 2009;39:981–93.CrossRefPubMed Tudor-Locke C, Lutes L. Why do pedometers work?: a reflection upon the factors related to successfully increasing physical activity. Sports Med. 2009;39:981–93.CrossRefPubMed
10.
go back to reference Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, Stave CD, Olkin I, Sirard JR. Using pedometers to increase physical activity and improve health - a systematic review. JAMA. 2007;298:2296–304.CrossRefPubMed Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, Stave CD, Olkin I, Sirard JR. Using pedometers to increase physical activity and improve health - a systematic review. JAMA. 2007;298:2296–304.CrossRefPubMed
11.
go back to reference Smith KM, Arthur HM, McKelvie RS, Kodis J. Differences in sustainability of exercise and health-related quality of life outcomes following home or hospital-based cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil. 2004;11:313–9.CrossRefPubMed Smith KM, Arthur HM, McKelvie RS, Kodis J. Differences in sustainability of exercise and health-related quality of life outcomes following home or hospital-based cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil. 2004;11:313–9.CrossRefPubMed
12.
go back to reference Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.CrossRefPubMedPubMedCentral Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.CrossRefPubMedPubMedCentral
13.
go back to reference American College of Sports Medicine. Guidelines for exercise testing and prescription. 8th ed. Philadelphia: Lippencott Williams & Wilkins; 2009. American College of Sports Medicine. Guidelines for exercise testing and prescription. 8th ed. Philadelphia: Lippencott Williams & Wilkins; 2009.
14.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed
15.
go back to reference Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511–22.CrossRefPubMed Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511–22.CrossRefPubMed
17.
go back to reference Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, Karila C, Lands LC, Lowman JD, Swisher A, Urquhart DS, European Cystic Fibrosis Exercise Working G. Statement on exercise testing in cystic fibrosis. Respiration. 2015;90:332–51.CrossRefPubMed Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, Karila C, Lands LC, Lowman JD, Swisher A, Urquhart DS, European Cystic Fibrosis Exercise Working G. Statement on exercise testing in cystic fibrosis. Respiration. 2015;90:332–51.CrossRefPubMed
18.
go back to reference Orenstein DM. Assessment of exercise pulmonary function. In: Rowland TW, editor. Pediatric laboratory exercise testing clinical guidelines. Champaign: Human Kinetics; 1993. p. 141–63. Orenstein DM. Assessment of exercise pulmonary function. In: Rowland TW, editor. Pediatric laboratory exercise testing clinical guidelines. Champaign: Human Kinetics; 1993. p. 141–63.
19.
go back to reference Ruf K, Fehn S, Bachmann M, Moeller A, Roth K, Kriemler S, Hebestreit H. Validation of activity questionnaires in patients with cystic fibrosis by Accelerometry and cycle Ergometry. BMC Med Res Methodol. 2012;12:43.CrossRefPubMedPubMedCentral Ruf K, Fehn S, Bachmann M, Moeller A, Roth K, Kriemler S, Hebestreit H. Validation of activity questionnaires in patients with cystic fibrosis by Accelerometry and cycle Ergometry. BMC Med Res Methodol. 2012;12:43.CrossRefPubMedPubMedCentral
20.
go back to reference Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128:2347–54.CrossRefPubMed Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128:2347–54.CrossRefPubMed
21.
go back to reference Wenninger K, Aussage P, Wahn U, Staab D. The revised German cystic fibrosis questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res. 2003;12:77–85.CrossRefPubMed Wenninger K, Aussage P, Wahn U, Staab D. The revised German cystic fibrosis questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res. 2003;12:77–85.CrossRefPubMed
22.
go back to reference Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the depression anxiety stress scales (DASS) in clinical samples. Behav Res Ther. 1997;35:79–89.CrossRefPubMed Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the depression anxiety stress scales (DASS) in clinical samples. Behav Res Ther. 1997;35:79–89.CrossRefPubMed
23.
go back to reference Crawford JR, Henry JD. The depression anxiety stress scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003;42:111–31.CrossRefPubMed Crawford JR, Henry JD. The depression anxiety stress scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003;42:111–31.CrossRefPubMed
24.
go back to reference Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the pediatric Endocrine Society. Diabetes Care. 2010;33:2697–708.CrossRefPubMedPubMedCentral Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the pediatric Endocrine Society. Diabetes Care. 2010;33:2697–708.CrossRefPubMedPubMedCentral
25.
go back to reference Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M, Tummler B, Vavrova V, De Boeck K. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF working group on outcome parameters in clinical trials. J Cyst Fibros. 2011;10(Suppl 2):S79–81.CrossRefPubMed Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M, Tummler B, Vavrova V, De Boeck K. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF working group on outcome parameters in clinical trials. J Cyst Fibros. 2011;10(Suppl 2):S79–81.CrossRefPubMed
26.
go back to reference Freedson P, Pober D, Janz KF. Calibration of accelerometer output for children. Med Sci Sports Exerc. 2005;37:S523–30.CrossRefPubMed Freedson P, Pober D, Janz KF. Calibration of accelerometer output for children. Med Sci Sports Exerc. 2005;37:S523–30.CrossRefPubMed
27.
go back to reference Kozey SL, Lyden K, Howe CA, Staudenmayer JW, Freedson PS. Accelerometer output and MET values of common physical activities. Med Sci Sports Exerc. 2010;42:1776–84.CrossRefPubMedPubMedCentral Kozey SL, Lyden K, Howe CA, Staudenmayer JW, Freedson PS. Accelerometer output and MET values of common physical activities. Med Sci Sports Exerc. 2010;42:1776–84.CrossRefPubMedPubMedCentral
28.
go back to reference Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40:181–8.CrossRefPubMed Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40:181–8.CrossRefPubMed
29.
go back to reference Trost SG, Loprinzi PD, Moore R, Pfeiffer KA. Comparison of accelerometer cut points for predicting activity intensity in youth. Med Sci Sports Exerc. 2011;43:1360–8.CrossRefPubMed Trost SG, Loprinzi PD, Moore R, Pfeiffer KA. Comparison of accelerometer cut points for predicting activity intensity in youth. Med Sci Sports Exerc. 2011;43:1360–8.CrossRefPubMed
30.
go back to reference Fuchs SI, Ellemunter H, Eder J, Mellies U, Grosse-Onnebrink J, Tummler B, Staab D, Jobst A, Griese M, Ripper J, Rietschel E, Zeidler S, Ahrens F, Gappa M. Feasibility and variability of measuring the lung clearance index in a multi-center setting. Pediatr Pulmonol. 2012;47:649–57.CrossRefPubMed Fuchs SI, Ellemunter H, Eder J, Mellies U, Grosse-Onnebrink J, Tummler B, Staab D, Jobst A, Griese M, Ripper J, Rietschel E, Zeidler S, Ahrens F, Gappa M. Feasibility and variability of measuring the lung clearance index in a multi-center setting. Pediatr Pulmonol. 2012;47:649–57.CrossRefPubMed
31.
go back to reference Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab. 2011;96:3160–9.CrossRefPubMedPubMedCentral Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab. 2011;96:3160–9.CrossRefPubMedPubMedCentral
32.
go back to reference Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, Tullis E, Lands LC, Coates AL, Corey M, Ratjen F. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. Eur Respir J. 2014;43:817–23.CrossRefPubMed Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, Tullis E, Lands LC, Coates AL, Corey M, Ratjen F. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. Eur Respir J. 2014;43:817–23.CrossRefPubMed
33.
go back to reference Cox NS, Alison JA, Button BM, Wilson JW, Morton JM, Holland AE. Physical activity participation by adults with cystic fibrosis: an observational study. Respirology. 2016;21:511–8. Cox NS, Alison JA, Button BM, Wilson JW, Morton JM, Holland AE. Physical activity participation by adults with cystic fibrosis: an observational study. Respirology. 2016;21:511–8.
34.
go back to reference Stanojevic S, Ratjen F. Physiologic endpoints for clinical studies for cystic fibrosis. J Cyst Fibros. 2016;15:416–23.CrossRefPubMed Stanojevic S, Ratjen F. Physiologic endpoints for clinical studies for cystic fibrosis. J Cyst Fibros. 2016;15:416–23.CrossRefPubMed
35.
go back to reference Tejero Garcia S, Giraldez Sanchez MA, Cejudo P, Quintana Gallego E, Dapena J, Garcia Jimenez R, Cano Luis P, Gomez de Terreros I. Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis. Chest. 2011;140:475–81.CrossRefPubMed Tejero Garcia S, Giraldez Sanchez MA, Cejudo P, Quintana Gallego E, Dapena J, Garcia Jimenez R, Cano Luis P, Gomez de Terreros I. Bone health, daily physical activity, and exercise tolerance in patients with cystic fibrosis. Chest. 2011;140:475–81.CrossRefPubMed
36.
go back to reference Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32:1626–31.CrossRefPubMedPubMedCentral Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32:1626–31.CrossRefPubMedPubMedCentral
37.
go back to reference Lauzon N, Chan CB, Myers AM, Tudor-Locke C. Participant experiences in a workplace pedometer-based physical activity program. J Phys Act Health. 2008;5:675–87.CrossRefPubMed Lauzon N, Chan CB, Myers AM, Tudor-Locke C. Participant experiences in a workplace pedometer-based physical activity program. J Phys Act Health. 2008;5:675–87.CrossRefPubMed
38.
go back to reference Lubans DR, Morgan PJ, Tudor-Locke C. A systematic review of studies using pedometers to promote physical activity among youth. Prev Med. 2009;48:307–15.CrossRefPubMed Lubans DR, Morgan PJ, Tudor-Locke C. A systematic review of studies using pedometers to promote physical activity among youth. Prev Med. 2009;48:307–15.CrossRefPubMed
39.
go back to reference Hospes G, Bossenbroek L, ten Hacken NHT, van Hengel P, de Greef MHG. Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exercise counseling program. Patient Educ Couns. 2009;75:274–8.CrossRefPubMed Hospes G, Bossenbroek L, ten Hacken NHT, van Hengel P, de Greef MHG. Enhancement of daily physical activity increases physical fitness of outclinic COPD patients: results of an exercise counseling program. Patient Educ Couns. 2009;75:274–8.CrossRefPubMed
40.
go back to reference Blaauwbroek R, Bouma MJ, Tuinier W, Groenier KH, de Greef MH, Meyboom-de Jong B, Kamps WA, Postma A. The effect of exercise counselling with feedback from a pedometer on fatigue in adult survivors of childhood cancer: a pilot study. Support Care Cancer. 2009;17:1041–8.CrossRefPubMed Blaauwbroek R, Bouma MJ, Tuinier W, Groenier KH, de Greef MH, Meyboom-de Jong B, Kamps WA, Postma A. The effect of exercise counselling with feedback from a pedometer on fatigue in adult survivors of childhood cancer: a pilot study. Support Care Cancer. 2009;17:1041–8.CrossRefPubMed
41.
go back to reference Strath SJ, Swartz AM, Parker SJ, Miller NE, Grimm EK, Cashin SE. A pilot randomized controlled trial evaluating motivationally matched pedometer feedback to increase physical activity behavior in older adults. J Phys Act Health. 2011;8:S267–74.CrossRefPubMedCentral Strath SJ, Swartz AM, Parker SJ, Miller NE, Grimm EK, Cashin SE. A pilot randomized controlled trial evaluating motivationally matched pedometer feedback to increase physical activity behavior in older adults. J Phys Act Health. 2011;8:S267–74.CrossRefPubMedCentral
Metadata
Title
Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): study protocol
Authors
Helge Hebestreit
Larry C. Lands
Nancy Alarie
Jonathan Schaeff
Chantal Karila
David M. Orenstein
Don S. Urquhart
Erik H. J. Hulzebos
Lothar Stein
Christian Schindler
Susi Kriemler
Thomas Radtke
the ACTIVATE-CF Study Working Group
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2018
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-018-0596-6

Other articles of this Issue 1/2018

BMC Pulmonary Medicine 1/2018 Go to the issue